Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Scientific Reports|June 30, 2022
Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomesRyoichi Maenosono, Tatsuo Fukushima, Daisuke Kobayashi, et al.
International Journal of Molecular Sciences|January 21, 2017
A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer CellsTomoaki Takai, Yuki Yoshikawa, Teruo Inamoto, et al.
Transplantation Proceedings|June 28, 2025
Use of Preoperative Renal Volumetry to Predict Postdonation Renal Function With Inulin Clearance as Indicator in JapanAsuka Sano, Takayuki Sugiyama, Shinsuke Isobe, et al.
Clinical Genitourinary Cancer|January 31, 2026
Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell CarcinomaLan Inoki, Shingo Toyoda, Wataru Fukuokaya, et al.
The Journal of Urology|December 21, 2010
Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancerPeter C Black, Gordon A Brown, Colin P Dinney, et al.
International Journal of Oncology|April 30, 2013
Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen)Haruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
Urology|June 25, 2014
Could transurethral resection of the prostate using the TURis system take over conventional monopolar transurethral resection of the prostate? A randomized controlled trial and midterm resultsKazumasa Komura, Teruo Inamoto, Tomoaki Takai, et al.
Transplantation Proceedings|May 24, 2020
Successful Treatment of Antibody-Mediated Rejection by De Novo Donor Specific Antibody After Primary Renal Transplantation in a Recipient From a Cadaveric Donor: A Case ReportTomohisa Matsunaga, Hajime Hirano, Ryoichi Maenosono, et al.
The Journal of Urology|July 22, 2008
Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?Wassim Kassouf, Gordon A Brown, Peter C Black, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 1, 2015
Feasibility of photodynamic diagnosis for challenging TUR- Bt cases including muscle invasive bladder cancer, BCG failure or 2nd-TURTomoaki Takai, Teruo Inamoto, Kazumasa Komura, et al.
Pageof 19